I agree that this site is using cookies. You can find further informations here.
X
Moeremans, K.
49  results:
Search for persons X
?
1

EE535 Economic Evaluation of Decennial Pertussis Vaccinatio..:

de Veras, B. ; Pinto, T. ; Moeremans, K....
Value in Health.  26 (2023)  6 - p. S157 , 2023
Link: https://doi.org/10.1016/..
 
?
2

PCN176 - A COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB VERS..:

Moeremans, K. ; Van Bellinghen, L. ; De Celle, T...
Value in Health.  21 (2018)  - p. S44 , 2018
Link: https://doi.org/10.1016/..
 
?
3

CP4 - WEIGHTED AVERAGE CALCULATIONS FOR POPULATING COST-EFF..:

Van Vlaenderen, I. ; Moeremans, K. ; Van Bellinghen, L.
Value in Health.  21 (2018)  - p. S5-S6 , 2018
Link: https://doi.org/10.1016/..
 
?
4

The impact of Local Skin Reactions (LSRS) on Resource Use a..:

Moeremans, K ; Van Vlaenderen, I ; Stijnen, B.
Value in Health.  19 (2016)  7 - p. A570 , 2016
Link: https://doi.org/10.1016/..
 
?
5

A Cost-Utility Analysis of Ranibizumab in Age-Related Macul..:

de Pouvourville, G. ; Lafuma, A. ; Moeremans, K....
Value in Health.  16 (2013)  7 - p. A507 , 2013
Link: https://doi.org/10.1016/..
 
?
6

PSS8 Non-Interventional Study on the Burden of Illness in D..:

Nivelle, E. ; Caekelbergh, K. ; Moeremans, K....
Value in Health.  15 (2012)  7 - p. A569 , 2012
Link: https://doi.org/10.1016/..
 
?
7

PSS14 COST-UTILITY ANALYSIS OF RANIBIZUMAB (LUCENTIS®) IN W..:

Moeremans, K. ; Gerlier, L. ; Drieskens, S....
Value in Health.  14 (2011)  3 - p. A55 , 2011
Link: https://doi.org/10.1016/..
 
?
8

PCN186 An Epidemiological Evaluation of Chemotherapy Used i..:

Chevalier, P. ; Moeremans, K.
Value in Health.  14 (2011)  7 - p. A468 , 2011
Link: https://doi.org/10.1016/..
 
?
9

PND35 Belgian Cost-Utility Analysis of Gilenya® (Fingolimod..:

Drieskens, S. ; Moeremans, K.
Value in Health.  14 (2011)  7 - p. A323 , 2011
Link: https://doi.org/10.1016/..
 
?
10

PCN130 QUALITY OF LIFE, OUTCOMES, AND COSTS IN THE BELGIAN ..:

Caekelbergh, K ; Moeremans, K
Value in Health.  13 (2010)  7 - p. A276 , 2010
Link: https://doi.org/10.1016/..
 
?
11

PSS20 COST-UTILITY ANALYSIS OF A PRN (AS NEEDED) TREATMENT ..:

Moeremans, K ; Gerlier, L ; Mitchell, P..
Value in Health.  13 (2010)  7 - p. A401 , 2010
Link: https://doi.org/10.1016/..
 
?
12

PIN58 COST-EFFECTIVENESS OF ETRAVIRINE IN SWEDEN IN TREATME..:

Moeremans, K ; Hjelmgren, J ; Martin, SO
Value in Health.  12 (2009)  7 - p. A428 , 2009
Link: https://doi.org/10.1016/..
 
?
13

PIN55 COST-EFFECTIVENESS OF DARUNAVIR/RITONAVIR 600/100MG B..:

Moeremans, K ; Hemmett, LC ; Hjelmgren, J..
Value in Health.  11 (2008)  6 - p. A435-A436 , 2008
Link: https://doi.org/10.1016/..
 
?
14

Cost-effectiveness of DRV/r 600/100 mg BID in treatment-exp..:

Moeremans, K ; Hemmett, LC ; Hjelmgren, J..
Journal of the International AIDS Society.  11 (2008)  Suppl 1 - p. P313 , 2008
Link: https://doi.org/10.1186/..
 
?
15

PSS26 PHARMACOECONOMIC EVALUATION OF RANIBIZUMAB IN THE TRE..:

Walter, E ; Brennig, C ; Moeremans, K.
Value in Health.  11 (2008)  6 - p. A617 , 2008
Link: https://doi.org/10.1016/..
 
1-15